A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity.

Activation of granzyme B, a key cytolytic effector molecule of natural killer (NK) cells, requires removal of an N-terminal pro-domain. In mice, cathepsin C is required for granzyme processing and normal NK cell cytolytic function, whereas in patients with Papillon-Lefèvre syndrome (PLS), loss-of-function mutations in cathepsin C do not affect lymphokine activated killer (LAK) cell function. Here we demonstrate that resting PLS NK cells do have a cytolytic defect and fail to induce the caspase cascade in target cells. NK cells from these patients contain inactive granzyme B, indicating that cathepsin C is required for granzyme B activation in unstimulated human NK cells. However, in vitro activation of PLS NK cells with interleukin-2 restores cytolytic function and granzyme B activity by a cathepsin C-independent mechanism. This is the first documented example of a human mutation affecting granzyme B activity and highlights the importance of cathepsin C in human NK cell function.

[1]  S. Gaffen,et al.  Overview of interleukin-2 function, production and clinical applications. , 2004, Cytokine.

[2]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[3]  D. Hudig,et al.  Activation of recombinant murine cytotoxic cell proteinase-1 requires deletion of an amino-terminal dipeptide. , 1993, The Journal of biological chemistry.

[4]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[5]  Emma Roberts,et al.  Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis , 1999, Nature Genetics.

[6]  J. Safrit,et al.  Visualization and quantification of T cell–mediated cytotoxicity using cell-permeable fluorogenic caspase substrates , 2002, Nature Medicine.

[7]  T. Ley,et al.  The orphan granzymes of humans and mice. , 2003, Current opinion in immunology.

[8]  J. Slots.  Update on human cytomegalovirus in destructive periodontal disease. , 2004, Oral microbiology and immunology.

[9]  T. Ley,et al.  Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.

[10]  T. Ley,et al.  Granzyme A initiates an alternative pathway for granule-mediated apoptosis. , 1999, Immunity.

[11]  S. W. Dahl,et al.  Active recombinant rat dipeptidyl aminopeptidase I (cathepsin C) produced using the baculovirus expression system. , 1998, Protein expression and purification.

[12]  L. Lebeck,et al.  Rapid flow cytometric assay for the assessment of natural killer cell activity. , 1993, Journal of immunological methods.

[13]  N H Sigal,et al.  Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. , 1991, The Journal of biological chemistry.

[14]  U. Gullberg,et al.  On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G. , 1998, Blood.

[15]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Bertram,et al.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. , 2003, Journal of immunological methods.

[17]  D. Bowden,et al.  Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome , 1999, Journal of medical genetics.

[18]  M. Smyth,et al.  Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. , 1995, Journal of immunology.

[19]  T. Ley,et al.  Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Orange.  Human natural killer cell deficiencies and susceptibility to infection. , 2002, Microbes and infection.

[21]  D Lamba,et al.  Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases , 2001, The EMBO journal.

[22]  M. Almuneef,et al.  Pyogenic liver abscess and Papillon-Lefèvre syndrome: not a rare association. , 2003, Pediatrics.

[23]  U. Gullberg,et al.  Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. , 2002, Experimental hematology.

[24]  P. Bird,et al.  The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency1 , 2003, The Journal of Immunology.

[25]  Andrew P Read,et al.  The role of cathepsin C in Papillon‐Lefèvre syndrome, prepubertal periodontitis, and aggressive periodontitis , 2004, Human mutation.